NCT00447681View on ClinicalTrials.gov

Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 31, 2006

Study Completion Date

November 30, 2007

Conditions
Healthy
Interventions
DRUG

ILV-094

Trial Locations (1)

19148

Philadelphia

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00447681 - Study of the Safety, Tolerability, Pharmacokinetics and Pharmcodynamics of ILV-094 in Healthy Subjects | Biotech Hunter | Biotech Hunter